1. BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma
   Yaodong He et al, 2024, Front. Immunol. CrossRef
2. Case report: Neoadjuvant-intent pembrolizumab resulted in complete response in a xeroderma pigmentosum patient with locally advanced resectable cutaneous squamous cell carcinoma of the nose
   Nader G. Zalaquett et al, 2024, Front. Med. CrossRef